18.220.227.250
dgid:
enl:
npi:0

-Advertisement-

Home Learn about a gel that treats dry eye symptoms by engaging the central nervous system

Dry Eye

Learn about a gel that treats dry eye symptoms by engaging the central nervous system

Watch Now

By rd360stg

Pretreatment improves outcomes with cyclosporine 0.1% in dry eye disease

By rd360stg

Study examines impact of cataract surgery on dry eye outcomes

By rd360stg

TRP channel modulators show promise in treating dry eye disease

By rd360stg

Prescription medications for dry eye disease: patient-centered treatment selection

-Advertisement-

-Advertisement-

-Advertisement-

By rd360stg

Top Videos: Innovations in Glaucoma, Retinal Disease, and Demodex Blepharitis Treatment

By rd360stg

Age, gender, and gland health tied to IPL results in dry eye treatment

By rd360stg

Study highlights timing benefits of eye drops for managing dry eye symptoms

By rd360stg

Does obstructive sleep apnea affect dry eye parameters?

-Advertisement-

-Advertisement-

-Advertisement-

By rd360stg

FDA accepts Aldeyra’s NDA for reproxalap, sets PDUFA date for April 2025

By rd360stg

AR-15512 shows promise in treating dry eye disease in Phase 3 studies

By rd360stg

A new era in dry eye therapy: the semifluorinated alkane-based cyclosporine A eye drop, VEVYE®

By rd360stg

Six months post-launch of LACRIFILL®️ Canalicular Gel for dry eye disease: what do we know?

-Advertisement-

-Advertisement-

Videos

Learn about a gel that treats dry eye symptoms by engaging the central nervous system

20 Jan, 2025

In the latest episode of The Ophthalmic Project, Mark Dlugoss...

Six months post-launch of LACRIFILL®️ Canalicular Gel for dry eye disease: what do we know?

06 Nov, 2024

-Advertisement-

-Advertisement-

Contact Info

Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809

+908-505-8899

[email protected]

Social Links

© 2025 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved

-Advertisement-

-Advertisement-